• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1.一种新型疏水标签可导致程序性死亡配体1的有效降解。
RSC Med Chem. 2024 Jul 4;15(9):3038-3047. doi: 10.1039/d4md00320a. eCollection 2024 Sep 19.
2
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.
3
PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics.程序性死亡受体1配体(PD-L1)诊断测试:评分算法和测试验证指标的系统文献综述
Diagn Pathol. 2018 Feb 9;13(1):12. doi: 10.1186/s13000-018-0689-9.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis.比较 PD-1/PD-L1 联合疗法在晚期 NSCLC 一线治疗中的疗效和安全性:一项更新的系统评价和网络荟萃分析。
Clin Transl Oncol. 2024 Oct;26(10):2488-2502. doi: 10.1007/s12094-024-03442-3. Epub 2024 Apr 16.
6
High matrix metalloproteinase-2 expression predicts poor prognosis of colon adenocarcinoma and is associated with PD-L1 expression and lymphocyte infiltration.高基质金属蛋白酶-2表达预示着结肠腺癌的预后不良,并与程序性死亡受体配体1(PD-L1)表达及淋巴细胞浸润相关。
PeerJ. 2025 Jun 30;13:e19550. doi: 10.7717/peerj.19550. eCollection 2025.
7
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
8
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
9
Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibody.小麦黄素通过抑制血小板衍生生长因子-BB(PDGF-BB)诱导的SRC/丝裂原活化蛋白激酶(MAPK)/活化蛋白-1(AP-1)/程序性死亡配体1(PD-L1)信号通路,选择性对抗KRAS突变的非小细胞肺癌,并增强抗程序性死亡蛋白1(PD-1)抗体的抗肿瘤作用。
Front Pharmacol. 2025 Jun 17;16:1594213. doi: 10.3389/fphar.2025.1594213. eCollection 2025.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

本文引用的文献

1
Targeting the PD-L1 cytoplasmic domain and its regulatory pathways to enhance cancer immunotherapy.针对 PD-L1 胞质结构域及其调控通路以增强癌症免疫治疗。
J Mol Cell Biol. 2024 Apr 10;15(11). doi: 10.1093/jmcb/mjad070.
2
UCSF ChimeraX: Tools for structure building and analysis.UCSF ChimeraX:结构构建和分析工具。
Protein Sci. 2023 Nov;32(11):e4792. doi: 10.1002/pro.4792.
3
Hydrophobic tag-based protein degradation: Development, opportunity and challenge.基于疏水标签的蛋白质降解:发展、机遇与挑战。
Eur J Med Chem. 2023 Nov 15;260:115741. doi: 10.1016/j.ejmech.2023.115741. Epub 2023 Aug 19.
4
Small-Molecule Hydrophobic Tagging: A Promising Strategy of Druglike Technology for Targeted Protein Degradation.小分子疏水标记:一种有前景的靶向蛋白降解类药技术策略。
J Med Chem. 2023 Aug 24;66(16):10917-10933. doi: 10.1021/acs.jmedchem.3c00736. Epub 2023 Aug 3.
5
Inside PD-1/PD-L1,2 with their inhibitors.在 PD-1/PD-L1 内及其抑制剂。
Eur J Med Chem. 2023 Aug 5;256:115465. doi: 10.1016/j.ejmech.2023.115465. Epub 2023 May 6.
6
Immune checkpoint therapy-current perspectives and future directions.免疫检查点治疗——现状与未来方向。
Cell. 2023 Apr 13;186(8):1652-1669. doi: 10.1016/j.cell.2023.03.006.
7
Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation.发现降冰片烯作为一种新型疏水性标签应用于蛋白质降解。
Angew Chem Int Ed Engl. 2023 Mar 20;62(13):e202217246. doi: 10.1002/anie.202217246. Epub 2023 Feb 8.
8
Hydrophobic Tag Tethering Degradation, The Emerging Targeted Protein Degradation Strategy.疏水标签连接降解,新兴的靶向蛋白降解策略。
Curr Med Chem. 2023;30(27):3137-3155. doi: 10.2174/0929867329666220930120328.
9
Targeted Protein Degradation via Lysosomes.通过溶酶体进行靶向蛋白降解。
Biochemistry. 2023 Feb 7;62(3):564-579. doi: 10.1021/acs.biochem.2c00310. Epub 2022 Sep 21.
10
Design, synthesis and biological evaluation of new dihydropyridine derivatives as PD-L1 degraders for enhancing antitumor immunity.设计、合成及新型二氢吡啶衍生物作为 PD-L1 降解剂的生物评价,用于增强抗肿瘤免疫。
Bioorg Chem. 2022 Aug;125:105820. doi: 10.1016/j.bioorg.2022.105820. Epub 2022 Apr 20.

一种新型疏水标签可导致程序性死亡配体1的有效降解。

A novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1.

作者信息

Gao Jieke, Xie Yongli, Zhang Jiantao, Chen Huirong, Zou Yan, Cen Shan, Zhou Jinming

机构信息

Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Department of Chemistry, Zhejiang Normal University 688 Yingbin Road Jinhua 321004 P. R. China

Institute of Medicinal Biotechnology, Chinese Academy of Medical Science Beijing China.

出版信息

RSC Med Chem. 2024 Jul 4;15(9):3038-3047. doi: 10.1039/d4md00320a. eCollection 2024 Sep 19.

DOI:10.1039/d4md00320a
PMID:39309365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11411611/
Abstract

The interaction of PD-L1 and PD-1 transmits the inhibitory signal to reduce the proliferation of antigen-specific T-cells in lymph nodes. The expression of PD-L1 confers a potential escaping mechanism of tumors from the host immune system. Blocking the interaction of PD-1 and PD-L1 enables tumor-reactive T cells to overcome regulatory mechanisms and induce an effective antitumor response. The hydrophobic tag tethering degrader (HyTTD) contains a hydrophobic moiety, binding to the protein of interest (POI) to mimic the misfolding state of the POI, thereby inducing the degradation of POI. In this work, using the HyTTD strategy, we selected the diphenylmethyl derivatives as the PD-L1 binding motif for PD-L1 to develop the degraders for PD-L1, and multiple hydrophobic tags were attached. As a result, two HyTTDs Z2d and Z3d efficiently decreased the protein level of PD-L1 in both NCI-H460 and HT-1080 cells with low cytotoxicity. Meanwhile, the reduction of PD-L1 protein levels by Z2d/Z3d was counteracted by , which indicated that Z2d/Z3d degraded PD-L1 through the proteasome pathway. Moreover, the molecular modeling results indicated that the HyT group of Z2d or Z3d extended the surface of the protein to mimic the misfold. Importantly, our work also identified a novel HyT, which could be applied to develop the HyTTD for other target proteins.

摘要

PD-L1与PD-1的相互作用传递抑制信号,以减少淋巴结中抗原特异性T细胞的增殖。PD-L1的表达赋予肿瘤一种逃避宿主免疫系统的潜在机制。阻断PD-1与PD-L1的相互作用可使肿瘤反应性T细胞克服调节机制并诱导有效的抗肿瘤反应。疏水标签连接降解剂(HyTTD)包含一个疏水部分,与目标蛋白(POI)结合以模拟POI的错误折叠状态,从而诱导POI的降解。在这项工作中,我们采用HyTTD策略,选择二苯甲基衍生物作为PD-L1的结合基序来开发PD-L1降解剂,并连接了多个疏水标签。结果,两种HyTTDs Z2d和Z3d在低细胞毒性的情况下有效降低了NCI-H460和HT-1080细胞中PD-L1的蛋白水平。同时,Z2d/Z3d对PD-L1蛋白水平的降低被……抵消,这表明Z2d/Z3d通过蛋白酶体途径降解PD-L1。此外,分子模拟结果表明,Z2d或Z3d的HyT基团扩展了蛋白质表面以模拟错误折叠。重要的是,我们的工作还鉴定出一种新型HyT,可用于开发针对其他靶蛋白的HyTTD。